Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.52 |
| ▸ | FABP3 | P05413 | 6/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115447 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL22534532 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL1490963 | 1.00 | CA1 (0.52) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL321998 | 0.98 | CA1 (0.54) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL610050 | 0.96 | ALDH1A1 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| Dodicin SCHEMBL29987916 | 0.96 | ALDH1A1 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL11627739 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL10484717 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR | |
| Potassium Ion SCHEMBL6660182 | 0.96 | FABP3 (0.53) | CA1FABP3EPHX1ALDH1A1TSHR | |
| SCHEMBL29543143 | 0.96 | FABP3 (0.50) | CA1FABP3EPHX1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1443886-A1 | SHAMPOO COMPOSITIONS WITH ANIONIC SURFACTANTS, AMPHOTERIC SURFACTANTS AND CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-11 | — | — | EP | claimed |
| US-20030108507-A1 | Shampoo compositions with anionic surfactants, amphoteric surfactants and cationic polymers | THE PROCTER & GAMBLE COMPANY | 2003-06-12 | — | — | US | claimed |
| WO-2003032935-A1 | SHAMPOO COMPOSITIONS WITH ANIONIC SURFACTANTS, AMPHOTERIC SURFACTANTS AND CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-24 | — | — | WO | claimed |
| US-20220079898-A1 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | IMUNEKS FARMA ILAC SAN. VE TIC. A.S. (TR) | 2022-03-17 | — | — | US | disclosed |
| US-20200188328-A1 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | IMUNEKS FARMA ILAC SAN. VE TIC. A.S. (TR) | 2020-06-18 | — | — | US | disclosed |
| EP-1443886-A1 | SHAMPOO COMPOSITIONS WITH ANIONIC SURFACTANTS, AMPHOTERIC SURFACTANTS AND CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-11 | — | — | EP | disclosed |
| US-20030108507-A1 | Shampoo compositions with anionic surfactants, amphoteric surfactants and cationic polymers | THE PROCTER & GAMBLE COMPANY | 2003-06-12 | — | — | US | disclosed |
| WO-2003032935-A1 | SHAMPOO COMPOSITIONS WITH ANIONIC SURFACTANTS, AMPHOTERIC SURFACTANTS AND CATIONIC POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-24 | — | — | WO | disclosed |
| US-4011180-A | NOVEL COCATALYST SYSTEM FOR TRIMERIZING POLYISOCYANATES | THE UPJOHN COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3986991-A | EPOXIDES, TERTIARY AMINE, GLYCINE SALT | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220079898-A1 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | KRT18, ANXA5, ANXA11 | CA1 512/4885FABP3 3396/4885EPHX1 2014/4885 |
| US-20030108507-A1 | Shampoo compositions with anionic surfactants, amphoteric surfactants and cationic polymers | SCO2, HAO2, PAOX | CA1 623/4885FABP3 1838/4885EPHX1 4032/4885 |
| US-20200188328-A1 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | KRT18, ANXA5, ANXA11 | CA1 512/4885FABP3 3396/4885EPHX1 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.